Cargando…
Engaging plasticity: Differentiation therapy in solid tumors
Cancer is a systemic heterogeneous disease that can undergo several rounds of latency and activation. Tumor progression evolves by increasing diversity, adaptation to signals from the microenvironment and escape mechanisms from therapy. These dynamic processes indicate necessity for cell plasticity....
Autores principales: | Bar-Hai, Neta, Ishay-Ronen, Dana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410762/ https://www.ncbi.nlm.nih.gov/pubmed/36034865 http://dx.doi.org/10.3389/fphar.2022.944773 |
Ejemplares similares
-
Clonal Evolution and Therapeutic Resistance in Solid Tumors
por: Barrett, Michael T., et al.
Publicado: (2013) -
Editorial: Novel Targets and Biomarkers in Solid Tumors
por: Shi, Zhi, et al.
Publicado: (2019) -
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
por: Gagliardi, Agnese, et al.
Publicado: (2021) -
System X(c)
(−)/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
por: Li, Feng-Jiao, et al.
Publicado: (2022) -
The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors
por: Lu, Suying, et al.
Publicado: (2022)